{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:36:29Z","timestamp":1782923789578,"version":"3.54.5"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00210-024-03757-6","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T15:53:48Z","timestamp":1735574028000},"page":"5057-5075","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Trace amine-associated receptor 1 (TAAR1): an emerging therapeutic target for neurodegenerative, neurodevelopmental, and neurotraumatic disorders"],"prefix":"10.1007","volume":"398","author":[{"given":"Saher","family":"Dalvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokesh Kumar","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"key":"3757_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1089\/thy.2019.0255","volume":"30","author":"A Accorroni","year":"2020","unstructured":"Accorroni A, Rutigliano G, Sabatini M et al (2020) Exogenous 3-iodothyronamine rescues the entorhinal cortex from \u03b2-amyloid toxicity. Thyroid 30:147\u2013160. https:\/\/doi.org\/10.1089\/thy.2019.0255","journal-title":"Thyroid"},{"key":"3757_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.pbb.2011.10.025","volume":"101","author":"C Achat-Mendes","year":"2012","unstructured":"Achat-Mendes C, Lynch LJ, Sullivan KA et al (2012) Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1. Pharmacol Biochem Behav 101:201\u2013207. https:\/\/doi.org\/10.1016\/j.pbb.2011.10.025","journal-title":"Pharmacol Biochem Behav"},{"key":"3757_CR3","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/ijnp\/pyad049","volume":"26","author":"R \u00c5gren","year":"2023","unstructured":"\u00c5gren R, Betari N, Saarinen M et al (2023) In vitro comparison of ulotaront (SEP-363856) and ralmitaront (RO6889450): two TAAR1 agonist candidate antipsychotics. Int J Neuropsychopharmacol 26:599\u2013606. https:\/\/doi.org\/10.1093\/ijnp\/pyad049","journal-title":"Int J Neuropsychopharmacol"},{"key":"3757_CR4","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1093\/neuros\/nyw080","volume":"80","author":"CS Ahuja","year":"2017","unstructured":"Ahuja CS, Nori S, Tetreault L et al (2017) Traumatic spinal cord injury-repair and regeneration. Neurosurgery 80:S9\u2013S22. https:\/\/doi.org\/10.1093\/neuros\/nyw080","journal-title":"Neurosurgery"},{"key":"3757_CR5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fneur.2019.00282","volume":"10","author":"A Alizadeh","year":"2019","unstructured":"Alizadeh A, Dyck SM, Karimi-Abdolrezaee S (2019) Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms. Front Neurol 10:282. https:\/\/doi.org\/10.3389\/fneur.2019.00282","journal-title":"Front Neurol"},{"key":"3757_CR6","doi-asserted-by":"publisher","first-page":"14057","DOI":"10.1523\/JNEUROSCI.1312-15.2015","volume":"35","author":"A Alvarsson","year":"2015","unstructured":"Alvarsson A, Zhang X, Stan TL et al (2015) Modulation by trace amine-associated receptor 1 of experimental parkinsonism, L-DOPA responsivity, and glutamatergic neurotransmission. J Neurosci Off J Soc Neurosci 35:14057\u201314069. https:\/\/doi.org\/10.1523\/JNEUROSCI.1312-15.2015","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"3757_CR7","doi-asserted-by":"publisher","first-page":"7533","DOI":"10.3390\/ijms21207533","volume":"21","author":"A Anjum","year":"2020","unstructured":"Anjum A, Yazid MD, Fauzi Daud M et al (2020) Spinal cord injury: pathophysiology, multimolecular interactions, and underlying recovery mechanisms. Int J Mol Sci 21:7533. https:\/\/doi.org\/10.3390\/ijms21207533","journal-title":"Int J Mol Sci"},{"key":"3757_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/bpa.12661","volume":"29","author":"A Arena","year":"2019","unstructured":"Arena A, Zimmer TS, van Scheppingen J et al (2019) Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence. Brain Pathol 29:351\u2013365. https:\/\/doi.org\/10.1111\/bpa.12661","journal-title":"Brain Pathol"},{"key":"3757_CR9","doi-asserted-by":"publisher","DOI":"10.1556\/2060.2022.00042","author":"EG B\u00e1n","year":"2022","unstructured":"B\u00e1n EG, Dho-Nagy EA, Brassai AM (2022) Effect of ractopamine on the release of dopamine from the striatum dissected from mice. Physiol Int. https:\/\/doi.org\/10.1556\/2060.2022.00042","journal-title":"Physiol Int"},{"key":"3757_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.pneurobio.2013.06.005","volume":"108","author":"A Bari","year":"2013","unstructured":"Bari A, Robbins TW (2013) Inhibition and impulsivity: behavioral and neural basis of response control. Prog Neurobiol 108:44\u201379. https:\/\/doi.org\/10.1016\/j.pneurobio.2013.06.005","journal-title":"Prog Neurobiol"},{"key":"3757_CR11","doi-asserted-by":"publisher","first-page":"11576","DOI":"10.3390\/ijms222111576","volume":"22","author":"DA Barnes","year":"2021","unstructured":"Barnes DA, Galloway DA, Hoener MC et al (2021) TAAR1 expression in human macrophages and brain tissue: a potential novel facet of MS neuroinflammation. Int J Mol Sci 22:11576. https:\/\/doi.org\/10.3390\/ijms222111576","journal-title":"Int J Mol Sci"},{"key":"3757_CR12","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1523\/JNEUROSCI.5074-06.2007","volume":"27","author":"J-M Beaulieu","year":"2007","unstructured":"Beaulieu J-M, Tirotta E, Sotnikova TD et al (2007) Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. J Neurosci Off J Soc Neurosci 27:881\u2013885. https:\/\/doi.org\/10.1523\/JNEUROSCI.5074-06.2007","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"3757_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fnmol.2011.00038","volume":"4","author":"J-M Beaulieu","year":"2011","unstructured":"Beaulieu J-M, Del\u2019guidice T, Sotnikova TD et al (2011) Beyond cAMP: the regulation of Akt and GSK3 by dopamine receptors. Front Mol Neurosci 4:38. https:\/\/doi.org\/10.3389\/fnmol.2011.00038","journal-title":"Front Mol Neurosci"},{"key":"3757_CR14","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3389\/fphar.2017.00905","volume":"8","author":"L Bellusci","year":"2017","unstructured":"Bellusci L, Laurino A, Sabatini M et al (2017) New insights into the potential roles of 3-iodothyronamine (T1AM) and newly developed thyronamine-like TAAR1 agonists in neuroprotection. Front Pharmacol 8:905. https:\/\/doi.org\/10.3389\/fphar.2017.00905","journal-title":"Front Pharmacol"},{"key":"3757_CR15","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3390\/molecules25051054","volume":"25","author":"L Bellusci","year":"2020","unstructured":"Bellusci L, Runfola M, Carnicelli V et al (2020) Endogenous 3-iodothyronamine (T1AM) and synthetic thyronamine-like analog SG-2 act as novel pleiotropic neuroprotective agents through the modulation of SIRT6. Molecules 25:1054. https:\/\/doi.org\/10.3390\/molecules25051054","journal-title":"Molecules"},{"key":"3757_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/157488707779318107","volume":"2","author":"MD Berry","year":"2007","unstructured":"Berry MD (2007) The potential of trace amines and their receptors for treating neurological and psychiatric diseases. Rev Recent Clin Trials 2:3\u201319. https:\/\/doi.org\/10.2174\/157488707779318107","journal-title":"Rev Recent Clin Trials"},{"key":"3757_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.pharmthera.2017.07.002","volume":"180","author":"MD Berry","year":"2017","unstructured":"Berry MD, Gainetdinov RR, Hoener MC, Shahid M (2017) Pharmacology of human trace amine-associated receptors: therapeutic opportunities and challenges. Pharmacol Ther 180:161\u2013180. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.07.002","journal-title":"Pharmacol Ther"},{"key":"3757_CR18","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00018-018-2988-4","volume":"76","author":"S B\u00f6lte","year":"2019","unstructured":"B\u00f6lte S, Girdler S, Marschik PB (2019) The contribution of environmental exposure to the etiology of autism spectrum disorder. Cell Mol Life Sci 76:1275\u20131297. https:\/\/doi.org\/10.1007\/s00018-018-2988-4","journal-title":"Cell Mol Life Sci"},{"key":"3757_CR19","doi-asserted-by":"publisher","first-page":"8966","DOI":"10.1073\/pnas.151105198","volume":"98","author":"B Borowsky","year":"2001","unstructured":"Borowsky B, Adham N, Jones KA et al (2001) Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci U S A 98:8966\u20138971. https:\/\/doi.org\/10.1073\/pnas.151105198","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3757_CR20","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.addr.2008.06.002","volume":"60","author":"M Bortolato","year":"2008","unstructured":"Bortolato M, Chen K, Shih JC (2008) Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv Drug Deliv Rev 60:1527\u20131533. https:\/\/doi.org\/10.1016\/j.addr.2008.06.002","journal-title":"Adv Drug Deliv Rev"},{"key":"3757_CR21","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1016\/0024-3205(74)90146-5","volume":"14","author":"AA Boulton","year":"1974","unstructured":"Boulton AA, Dyck LE (1974) Biosynthesis and excretion of meta and para tyramine in the rat. Life Sci 14:2497\u20132506. https:\/\/doi.org\/10.1016\/0024-3205(74)90146-5","journal-title":"Life Sci"},{"key":"3757_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1139\/o72-037","volume":"50","author":"AA Boulton","year":"1972","unstructured":"Boulton AA, Wu PH (1972) Biosynthesis of cerebral phenolic amines. I. In vivo formation of p-tyramine, octopamine, and synephrine. Can J Biochem 50:261\u2013267. https:\/\/doi.org\/10.1139\/o72-037","journal-title":"Can J Biochem"},{"key":"3757_CR23","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1139\/o73-050","volume":"51","author":"AA Boulton","year":"1973","unstructured":"Boulton AA, Wu PH (1973) Biosynthesis of cerebral phenolic amines. II. In vivo regional formation of p-tyramine and octopamine from tyrosine and dopamine. Can J Biochem 51:428\u2013435. https:\/\/doi.org\/10.1139\/o73-050","journal-title":"Can J Biochem"},{"key":"3757_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fncel.2013.00157","volume":"7","author":"Y Bozzi","year":"2013","unstructured":"Bozzi Y, Borrelli E (2013) The role of dopamine signaling in epileptogenesis. Front Cell Neurosci 7:157. https:\/\/doi.org\/10.3389\/fncel.2013.00157","journal-title":"Front Cell Neurosci"},{"key":"3757_CR25","doi-asserted-by":"publisher","first-page":"20081","DOI":"10.1073\/PNAS.0906522106","volume":"106","author":"A Bradaia","year":"2009","unstructured":"Bradaia A, Trube G, Stalder H et al (2009) The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system. Proc Natl Acad Sci U S A 106:20081\u201320086. https:\/\/doi.org\/10.1073\/PNAS.0906522106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3757_CR26","unstructured":"Bromfield EB, Cavazos JE, Sirven JI (2006) Basic mechanisms underlying seizures and epilepsy"},{"key":"3757_CR27","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3390\/ph14101057","volume":"14","author":"A Cano","year":"2021","unstructured":"Cano A, Fonseca E, Ettcheto M et al (2021) Epilepsy in neurodegenerative diseases: related drugs and molecular pathways. Pharmaceuticals (Basel) 14:1057. https:\/\/doi.org\/10.3390\/ph14101057","journal-title":"Pharmaceuticals (Basel)"},{"key":"3757_CR28","doi-asserted-by":"publisher","first-page":"E3544","DOI":"10.1073\/pnas.1413201111","volume":"111","author":"G Caraveo","year":"2014","unstructured":"Caraveo G, Auluck PK, Whitesell L et al (2014) Calcineurin determines toxic versus beneficial responses to \u03b1-synuclein. Proc Natl Acad Sci U S A 111:E3544-52. https:\/\/doi.org\/10.1073\/pnas.1413201111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3757_CR29","doi-asserted-by":"publisher","first-page":"E11313","DOI":"10.1073\/pnas.1711926115","volume":"114","author":"G Caraveo","year":"2017","unstructured":"Caraveo G, Soste M, Cappelleti V et al (2017) FKBP12 contributes to \u03b1-synuclein toxicity by regulating the calcineurin-dependent phosphoproteome. Proc Natl Acad Sci U S A 114:E11313\u2013E11322. https:\/\/doi.org\/10.1073\/pnas.1711926115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3757_CR30","doi-asserted-by":"publisher","first-page":"107583","DOI":"10.1016\/j.pharmthera.2020.107583","volume":"213","author":"R Chen","year":"2020","unstructured":"Chen R, Ferris MJ, Wang S (2020) Dopamine D2 autoreceptor interactome: targeting the receptor complex as a strategy for treatment of substance use disorder. Pharmacol Ther 213:107583. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107583","journal-title":"Pharmacol Ther"},{"key":"3757_CR31","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41594-019-0253-7","volume":"26","author":"MH Cheng","year":"2019","unstructured":"Cheng MH, Bahar I (2019) Monoamine transporters: structure, intrinsic dynamics and allosteric regulation. Nat Struct Mol Biol 26:545\u2013556. https:\/\/doi.org\/10.1038\/s41594-019-0253-7","journal-title":"Nat Struct Mol Biol"},{"key":"3757_CR32","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.neuropharm.2014.06.011","volume":"85","author":"IE Cisneros","year":"2014","unstructured":"Cisneros IE, Ghorpade A (2014) Methamphetamine and HIV-1-induced neurotoxicity: role of trace amine associated receptor 1 cAMP signaling in astrocytes. Neuropharmacology 85:499\u2013507. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.06.011","journal-title":"Neuropharmacology"},{"key":"3757_CR33","doi-asserted-by":"publisher","first-page":"593146","DOI":"10.3389\/fneur.2020.593146","volume":"11","author":"IE Cisneros","year":"2020","unstructured":"Cisneros IE, Ghorpade A, Borgmann K (2020) Methamphetamine activates trace amine associated receptor 1 to regulate astrocyte excitatory amino acid transporter-2 via differential CREB phosphorylation during HIV-associated neurocognitive disorders. Front Neurol 11:593146. https:\/\/doi.org\/10.3389\/fneur.2020.593146","journal-title":"Front Neurol"},{"key":"3757_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41537-021-00190-z","volume":"7","author":"CU Correll","year":"2021","unstructured":"Correll CU, Koblan KS, Hopkins SC et al (2021) Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study. NPJ Schizophr 7:63. https:\/\/doi.org\/10.1038\/s41537-021-00190-z","journal-title":"NPJ Schizophr"},{"key":"3757_CR35","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.neulet.2009.12.025","volume":"469","author":"G D\u2019Andrea","year":"2010","unstructured":"D\u2019Andrea G, Nordera G, Pizzolato G et al (2010) Trace amine metabolism in Parkinson\u2019s disease: low circulating levels of octopamine in early disease stages. Neurosci Lett 469:348\u2013351. https:\/\/doi.org\/10.1016\/j.neulet.2009.12.025","journal-title":"Neurosci Lett"},{"key":"3757_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/jnc.14606","volume":"148","author":"S Dave","year":"2019","unstructured":"Dave S, Chen L, Yu C et al (2019) Methamphetamine decreases K(+) channel function in human fetal astrocytes by activating the trace amine-associated receptor type-1. J Neurochem 148:29\u201345. https:\/\/doi.org\/10.1111\/jnc.14606","journal-title":"J Neurochem"},{"key":"3757_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0165-0173(00)00021-7","volume":"33","author":"GV De Ferrari","year":"2000","unstructured":"De Ferrari GV, Inestrosa NC (2000) Wnt signaling function in Alzheimer\u2019s disease. Brain Res Brain Res Rev 33:1\u201312. https:\/\/doi.org\/10.1016\/s0165-0173(00)00021-7","journal-title":"Brain Res Brain Res Rev"},{"key":"3757_CR38","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fpsyt.2017.00118","volume":"8","author":"JC de Jonge","year":"2017","unstructured":"de Jonge JC, Vinkers CH, Hulshoff Pol HE, Marsman A (2017) GABAergic mechanisms in schizophrenia: linking postmortem and in vivo studies. Front psychiatry 8:118. https:\/\/doi.org\/10.3389\/fpsyt.2017.00118","journal-title":"Front psychiatry"},{"key":"3757_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.119.260281","volume":"371","author":"N Dedic","year":"2019","unstructured":"Dedic N, Jones PG, Hopkins SC et al (2019) SEP-363856, a novel psychotropic agent with a unique, non-D(2) Receptor mechanism of action. J Pharmacol Exp Ther 371:1\u201314. https:\/\/doi.org\/10.1124\/jpet.119.260281","journal-title":"J Pharmacol Exp Ther"},{"key":"3757_CR40","doi-asserted-by":"publisher","first-page":"13185","DOI":"10.3390\/ijms222413185","volume":"22","author":"N Dedic","year":"2021","unstructured":"Dedic N, Dworak H, Zeni C et al (2021) Therapeutic potential of TAAR1 agonists in schizophrenia: evidence from preclinical models and clinical studies. Int J Mol Sci 22:13185. https:\/\/doi.org\/10.3390\/ijms222413185","journal-title":"Int J Mol Sci"},{"key":"3757_CR41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/biomedicines8060145","volume":"8","author":"S Dhakal","year":"2020","unstructured":"Dhakal S, Macreadie I (2020) Tyramine and amyloid beta 42: a toxic synergy. Biomedicines 8:145. https:\/\/doi.org\/10.3390\/biomedicines8060145","journal-title":"Biomedicines"},{"key":"3757_CR42","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.4103\/1673-5374.300985","volume":"16","author":"S Dhakal","year":"2021","unstructured":"Dhakal S, Macreadie I (2021) Potential contributions of trace amines in Alzheimer\u2019s disease and therapeutic prospects. Neural Regen Res 16:1394\u20131396. https:\/\/doi.org\/10.4103\/1673-5374.300985","journal-title":"Neural Regen Res"},{"key":"3757_CR43","doi-asserted-by":"publisher","first-page":"5090","DOI":"10.3390\/ijms20205090","volume":"20","author":"S Dhakal","year":"2019","unstructured":"Dhakal S, Kushairi N, Phan CW et al (2019) Dietary polyphenols: a multifactorial strategy to target Alzheimer\u2019s disease. Int J Mol Sci 20:5090. https:\/\/doi.org\/10.3390\/ijms20205090","journal-title":"Int J Mol Sci"},{"key":"3757_CR44","doi-asserted-by":"publisher","first-page":"16928","DOI":"10.1523\/JNEUROSCI.2502-11.2011","volume":"31","author":"B Di Cara","year":"2011","unstructured":"Di Cara B, Maggio R, Aloisi G et al (2011) Genetic deletion of trace amine 1 receptors reveals their role in auto-inhibiting the actions of ecstasy (MDMA). J Neurosci Off J Soc Neurosci 31:16928\u201316940. https:\/\/doi.org\/10.1523\/JNEUROSCI.2502-11.2011","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"3757_CR45","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuroscience.2017.09.040","volume":"365","author":"S Ding","year":"2017","unstructured":"Ding S, Wang X, Zhuge W et al (2017) Dopamine induces glutamate accumulation in astrocytes to disrupt neuronal function leading to pathogenesis of minimal hepatic encephalopathy. Neuroscience 365:94\u2013113. https:\/\/doi.org\/10.1016\/j.neuroscience.2017.09.040","journal-title":"Neuroscience"},{"key":"3757_CR46","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.neubiorev.2020.09.028","volume":"120","author":"S Dodd","year":"2021","unstructured":"Dodd S, Carvalho FA, Puri BK et al (2021) Trace amine-associated receptor 1 (TAAR1): a new drug target for psychiatry? Neurosci Biobehav Rev 120:537\u2013541. https:\/\/doi.org\/10.1016\/j.neubiorev.2020.09.028","journal-title":"Neurosci Biobehav Rev"},{"key":"3757_CR47","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00429-008-0189-x","volume":"213","author":"WC Drevets","year":"2008","unstructured":"Drevets WC, Price JL, Furey ML (2008) Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 213:93\u2013118. https:\/\/doi.org\/10.1007\/s00429-008-0189-x","journal-title":"Brain Struct Funct"},{"key":"3757_CR48","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/jnc.14675","volume":"149","author":"PR Dunkley","year":"2019","unstructured":"Dunkley PR, Dickson PW (2019) Tyrosine hydroxylase phosphorylation in vivo. J Neurochem 149:706\u2013728. https:\/\/doi.org\/10.1111\/jnc.14675","journal-title":"J Neurochem"},{"key":"3757_CR49","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/jnr.490100209","volume":"10","author":"LE Dyck","year":"1983","unstructured":"Dyck LE, Yang CR, Boulton AA (1983) The biosynthesis of p-tyramine, m-tyramine, and beta-phenylethylamine by rat striatal slices. J Neurosci Res 10:211\u2013220. https:\/\/doi.org\/10.1002\/jnr.490100209","journal-title":"J Neurosci Res"},{"key":"3757_CR50","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1124\/mol.111.073304","volume":"80","author":"S Espinoza","year":"2011","unstructured":"Espinoza S, Salahpour A, Masri B et al (2011) Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor. Mol Pharmacol 80:416\u2013425. https:\/\/doi.org\/10.1124\/mol.111.073304","journal-title":"Mol Pharmacol"},{"key":"3757_CR51","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.neuropharm.2015.02.010","volume":"93","author":"S Espinoza","year":"2015","unstructured":"Espinoza S, Ghisi V, Emanuele M et al (2015) Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1. Neuropharmacology 93:308\u2013313. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.02.010","journal-title":"Neuropharmacology"},{"key":"3757_CR52","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1038\/npp.2015.65","volume":"40","author":"S Espinoza","year":"2015","unstructured":"Espinoza S, Lignani G, Caffino L et al (2015) TAAR1 modulates cortical glutamate NMDA receptor function. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 40:2217\u20132227. https:\/\/doi.org\/10.1038\/npp.2015.65","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"3757_CR53","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.biopsych.2004.11.024","volume":"57","author":"SV Faraone","year":"2005","unstructured":"Faraone SV, Perlis RH, Doyle AE et al (2005) Molecular genetics of attention-deficit\/hyperactivity disorder. Biol Psychiatry 57:1313\u20131323. https:\/\/doi.org\/10.1016\/j.biopsych.2004.11.024","journal-title":"Biol Psychiatry"},{"key":"3757_CR54","doi-asserted-by":"publisher","unstructured":"Farooqui AA (2010) Neurochemical aspects of neurotraumatic and neurodegenerative diseases. Neurochem Asp Neurotraumatic Neurodegener Dis 1\u2013401. https:\/\/doi.org\/10.1007\/978-1-4419-6652-0\/COVER","DOI":"10.1007\/978-1-4419-6652-0\/COVER"},{"key":"3757_CR55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.seizure.2022.07.007","volume":"101","author":"Y Feng","year":"2022","unstructured":"Feng Y, Wei Z-H, Liu C et al (2022) Genetic variations in GABA metabolism and epilepsy. Seizure 101:22\u201329. https:\/\/doi.org\/10.1016\/j.seizure.2022.07.007","journal-title":"Seizure"},{"key":"3757_CR56","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3389\/fnins.2018.00255","volume":"12","author":"N Fujikake","year":"2018","unstructured":"Fujikake N, Shin M, Shimizu S (2018) Association between autophagy and neurodegenerative diseases. Front Neurosci 12:255. https:\/\/doi.org\/10.3389\/fnins.2018.00255","journal-title":"Front Neurosci"},{"key":"3757_CR57","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1126\/science.283.5400.397","volume":"283","author":"RR Gainetdinov","year":"1999","unstructured":"Gainetdinov RR, Wetsel WC, Jones SR et al (1999) Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283:397\u2013401. https:\/\/doi.org\/10.1126\/science.283.5400.397","journal-title":"Science"},{"key":"3757_CR58","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1124\/pr.117.015305","volume":"70","author":"RR Gainetdinov","year":"2018","unstructured":"Gainetdinov RR, Hoener MC, Berry MD (2018) Trace amines and their receptors. Pharmacol Rev 70:549\u2013620. https:\/\/doi.org\/10.1124\/pr.117.015305","journal-title":"Pharmacol Rev"},{"key":"3757_CR59","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1528-1167.2012.03506.x","volume":"53","author":"AS Galanopoulou","year":"2012","unstructured":"Galanopoulou AS, Gorter JA, Cepeda C (2012) Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target. Epilepsia 53:1119\u20131130. https:\/\/doi.org\/10.1111\/j.1528-1167.2012.03506.x","journal-title":"Epilepsia"},{"key":"3757_CR60","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1001\/JAMANEUROL.2019.1708","volume":"76","author":"M Galovic","year":"2019","unstructured":"Galovic M, Van Dooren VQH, Postma TS et al (2019) Progressive cortical thinning in patients with focal epilepsy. JAMA Neurol 76:1230\u20131239. https:\/\/doi.org\/10.1001\/JAMANEUROL.2019.1708","journal-title":"JAMA Neurol"},{"key":"3757_CR61","doi-asserted-by":"publisher","unstructured":"Gawade S (2022) Perspectives of presynaptic autoreceptors and presynaptic heteroreceptors in the mechanism of neurotransmission. Indian J Pharm Educ Res 329\u2013346. https:\/\/doi.org\/10.5530\/ijper.56.2.53","DOI":"10.5530\/ijper.56.2.53"},{"key":"3757_CR62","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3389\/fncir.2014.00134","volume":"8","author":"EA Gozal","year":"2014","unstructured":"Gozal EA, O\u2019Neill BE, Sawchuk MA et al (2014) Anatomical and functional evidence for trace amines as unique modulators of locomotor function in the mammalian spinal cord. Front Neural Circuits 8:134. https:\/\/doi.org\/10.3389\/fncir.2014.00134","journal-title":"Front Neural Circuits"},{"key":"3757_CR63","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.pharmthera.2007.06.007","volume":"116","author":"DK Grandy","year":"2007","unstructured":"Grandy DK (2007) Trace amine-associated receptor 1-family archetype or iconoclast? Pharmacol Ther 116:355\u2013390. https:\/\/doi.org\/10.1016\/j.pharmthera.2007.06.007","journal-title":"Pharmacol Ther"},{"key":"3757_CR64","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fphar.2015.00235","volume":"6","author":"J Grouleff","year":"2015","unstructured":"Grouleff J, Ladefoged LK, Kolds\u00f8 H, Schi\u00f8tt B (2015) Monoamine transporters: insights from molecular dynamics simulations. Front Pharmacol 6:235. https:\/\/doi.org\/10.3389\/fphar.2015.00235","journal-title":"Front Pharmacol"},{"key":"3757_CR65","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/J.TINS.2022.10.010","volume":"46","author":"EF Halff","year":"2023","unstructured":"Halff EF, Rutigliano G, Garcia-Hidalgo A, Howes OD (2023) Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders. Trends Neurosci 46:60\u201374. https:\/\/doi.org\/10.1016\/J.TINS.2022.10.010","journal-title":"Trends Neurosci"},{"key":"3757_CR66","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.euroneuro.2015.08.011","volume":"25","author":"A Harmeier","year":"2015","unstructured":"Harmeier A, Obermueller S, Meyer CA et al (2015) Trace amine-associated receptor 1 activation silences GSK3\u03b2 signaling of TAAR1 and D2R heteromers. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 25:2049\u20132061. https:\/\/doi.org\/10.1016\/j.euroneuro.2015.08.011","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"key":"3757_CR67","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1021\/acschemneuro.7b00034","volume":"8","author":"A Herrera","year":"2017","unstructured":"Herrera A, Mu\u00f1oz P, Steinbusch HWM, Segura-Aguilar J (2017) Are dopamine oxidation metabolites involved in the loss of dopaminergic neurons in the nigrostriatal system in Parkinson\u2019s disease? ACS Chem Neurosci 8:702\u2013711. https:\/\/doi.org\/10.1021\/acschemneuro.7b00034","journal-title":"ACS Chem Neurosci"},{"key":"3757_CR68","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.21037\/tp.2019.09.09","volume":"9","author":"H Hodges","year":"2020","unstructured":"Hodges H, Fealko C, Soares N (2020) Autism spectrum disorder: definition, epidemiology, causes, and clinical evaluation. Transl Pediatr 9:S55\u2013S65. https:\/\/doi.org\/10.21037\/tp.2019.09.09","journal-title":"Transl Pediatr"},{"key":"3757_CR69","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12640-012-9348-1","volume":"23","author":"LL Hurley","year":"2013","unstructured":"Hurley LL, Tizabi Y (2013) Neuroinflammation, neurodegeneration, and depression. Neurotox Res 23:131\u2013144. https:\/\/doi.org\/10.1007\/s12640-012-9348-1","journal-title":"Neurotox Res"},{"key":"3757_CR70","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/jnr.24121","volume":"96","author":"MJ Hylin","year":"2018","unstructured":"Hylin MJ, Zhao J, Tangavelou K et al (2018) A role for autophagy in long-term spatial memory formation in male rodents. J Neurosci Res 96:416\u2013426. https:\/\/doi.org\/10.1002\/jnr.24121","journal-title":"J Neurosci Res"},{"key":"3757_CR71","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1111\/j.1471-4159.1985.tb07180.x","volume":"44","author":"KE Ibrahim","year":"1985","unstructured":"Ibrahim KE, Couch MW, Williams CM et al (1985) m-Octopamine: normal occurrence with p-octopamine in mammalian sympathetic nerves. J Neurochem 44:1862\u20131867. https:\/\/doi.org\/10.1111\/j.1471-4159.1985.tb07180.x","journal-title":"J Neurochem"},{"key":"3757_CR72","doi-asserted-by":"publisher","first-page":"e200175","DOI":"10.1212\/CPJ.0000000000200175","volume":"13","author":"SH Isaacson","year":"2023","unstructured":"Isaacson SH, Goldstein M, Pahwa R et al (2023) Ulotaront, a trace amine-associated receptor 1\/serotonin 5-HT(1A) agonist, in patients with Parkinson disease psychosis: a pilot study. Neurol Clin Pract 13:e200175. https:\/\/doi.org\/10.1212\/CPJ.0000000000200175","journal-title":"Neurol Clin Pract"},{"key":"3757_CR73","doi-asserted-by":"publisher","first-page":"11765","DOI":"10.1038\/srep11765","volume":"5","author":"J Jiang","year":"2015","unstructured":"Jiang J, Wang Z-H, Qu M et al (2015) Stimulation of EphB2 attenuates tau phosphorylation through PI3K\/Akt-mediated inactivation of glycogen synthase kinase-3\u03b2. Sci Rep 5:11765. https:\/\/doi.org\/10.1038\/srep11765","journal-title":"Sci Rep"},{"key":"3757_CR74","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.biopha.2016.07.002","volume":"83","author":"MZ Khan","year":"2016","unstructured":"Khan MZ, Nawaz W (2016) The emerging roles of human trace amines and human trace amine-associated receptors (hTAARs) in central nervous system. Biomed Pharmacother 83:439\u2013449. https:\/\/doi.org\/10.1016\/j.biopha.2016.07.002","journal-title":"Biomed Pharmacother"},{"key":"3757_CR75","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.brainresbull.2021.03.018","volume":"171","author":"Q Kong","year":"2021","unstructured":"Kong Q, Zhang H, Wang M et al (2021) The TAAR1 inhibitor EPPTB suppresses neuronal excitability and seizure activity in mice. Brain Res Bull 171:142\u2013149. https:\/\/doi.org\/10.1016\/j.brainresbull.2021.03.018","journal-title":"Brain Res Bull"},{"key":"3757_CR76","doi-asserted-by":"publisher","first-page":"104460","DOI":"10.1016\/j.neuint.2019.05.004","volume":"129","author":"E Landucci","year":"2019","unstructured":"Landucci E, Gencarelli M, Mazzantini C et al (2019) N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity. Neurochem Int 129:104460. https:\/\/doi.org\/10.1016\/j.neuint.2019.05.004","journal-title":"Neurochem Int"},{"key":"3757_CR77","doi-asserted-by":"publisher","first-page":"118664","DOI":"10.1016\/j.bbamcr.2020.118664","volume":"1867","author":"E Lauretti","year":"2020","unstructured":"Lauretti E, Dincer O, Pratic\u00f2 D (2020) Glycogen synthase kinase-3 signaling in Alzheimer\u2019s disease. Biochim Biophys acta Mol cell Res 1867:118664. https:\/\/doi.org\/10.1016\/j.bbamcr.2020.118664","journal-title":"Biochim Biophys acta Mol cell Res"},{"key":"3757_CR78","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ejphar.2015.04.038","volume":"761","author":"A Laurino","year":"2015","unstructured":"Laurino A, De Siena G, Saba A et al (2015) In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine. Eur J Pharmacol 761:130\u2013134. https:\/\/doi.org\/10.1016\/j.ejphar.2015.04.038","journal-title":"Eur J Pharmacol"},{"key":"3757_CR79","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1111\/j.1476-5381.2010.00792.x","volume":"160","author":"A Ledonne","year":"2010","unstructured":"Ledonne A, Federici M, Giustizieri M et al (2010) Trace amines depress D(2)-autoreceptor-mediated responses on midbrain dopaminergic cells. Br J Pharmacol 160:1509\u20131520. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00792.x","journal-title":"Br J Pharmacol"},{"key":"3757_CR80","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.4103\/1673-5374.241453","volume":"13","author":"D Leo","year":"2018","unstructured":"Leo D, Sukhanov I, Gainetdinov RR (2018) Novel translational rat models of dopamine transporter deficiency. Neural Regen Res 13:2091\u20132093. https:\/\/doi.org\/10.4103\/1673-5374.241453","journal-title":"Neural Regen Res"},{"key":"3757_CR81","doi-asserted-by":"publisher","first-page":"7811","DOI":"10.3390\/ijms23147811","volume":"23","author":"D Leo","year":"2022","unstructured":"Leo D, Targa G, Espinoza S et al (2022) Trace amine associate receptor 1 (TAAR1) as a new target for the treatment of cognitive dysfunction in Alzheimer\u2019s disease. Int J Mol Sci 23:7811. https:\/\/doi.org\/10.3390\/ijms23147811","journal-title":"Int J Mol Sci"},{"key":"3757_CR82","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tcb.2010.09.011","volume":"21","author":"H Li","year":"2011","unstructured":"Li H, Rao A, Hogan PG (2011) Interaction of calcineurin with substrates and targeting proteins. Trends Cell Biol 21:91\u2013103. https:\/\/doi.org\/10.1016\/j.tcb.2010.09.011","journal-title":"Trends Cell Biol"},{"key":"3757_CR83","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/npp.2016.278","volume":"42","author":"M-H Li","year":"2017","unstructured":"Li M-H, Underhill SM, Reed C et al (2017) Amphetamine and methamphetamine increase NMDAR-GluN2B synaptic currents in midbrain dopamine neurons. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 42:1539\u20131547. https:\/\/doi.org\/10.1038\/npp.2016.278","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"3757_CR84","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nature05066","volume":"442","author":"SD Liberles","year":"2006","unstructured":"Liberles SD, Buck LB (2006) A second class of chemosensory receptors in the olfactory epithelium. Nature 442:645\u2013650. https:\/\/doi.org\/10.1038\/nature05066","journal-title":"Nature"},{"key":"3757_CR85","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/978-3-540-38918-7_203","volume-title":"Encyclopedia of molecular pharmacology","author":"L Lindemann","year":"2008","unstructured":"Lindemann L, Hoener MC (2008) Trace Amines. In: Offermanns S, Rosenthal W (eds) Encyclopedia of molecular pharmacology. Springer, Berlin Heidelberg, Berlin, Heidelberg, pp 1217\u20131223"},{"key":"3757_CR86","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1124\/jpet.107.132647","volume":"324","author":"L Lindemann","year":"2008","unstructured":"Lindemann L, Meyer CA, Jeanneau K et al (2008) Trace amine-associated receptor 1 modulates dopaminergic activity. J Pharmacol Exp Ther 324:948\u2013956. https:\/\/doi.org\/10.1124\/jpet.107.132647","journal-title":"J Pharmacol Exp Ther"},{"key":"3757_CR87","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fphar.2018.00279","volume":"9","author":"J-F Liu","year":"2018","unstructured":"Liu J-F, Li J-X (2018) TAAR1 in addiction: looking beyond the tip of the iceberg. Front Pharmacol 9:279. https:\/\/doi.org\/10.3389\/fphar.2018.00279","journal-title":"Front Pharmacol"},{"key":"3757_CR88","first-page":"736","volume":"48","author":"J Lv","year":"2018","unstructured":"Lv J, Liao J, Tan W et al (2018) 3-Iodothyronamine acting through an anti-apoptotic mechanism is neuroprotective against spinal cord injury in rats. Ann Clin Lab Sci 48:736\u2013742","journal-title":"Ann Clin Lab Sci"},{"key":"3757_CR89","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejmech.2015.10.018","volume":"107","author":"M Maqbool","year":"2016","unstructured":"Maqbool M, Mobashir M, Hoda N (2016) Pivotal role of glycogen synthase kinase-3: a therapeutic target for Alzheimer\u2019s disease. Eur J Med Chem 107:63\u201381. https:\/\/doi.org\/10.1016\/j.ejmech.2015.10.018","journal-title":"Eur J Med Chem"},{"key":"3757_CR90","doi-asserted-by":"publisher","unstructured":"Marin SE, Haas RH (2016) Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Mitochondrial Case Stud Underlying Mech Diagnosis 13\u201329. https:\/\/doi.org\/10.1016\/B978-0-12-800877-5.00002-4","DOI":"10.1016\/B978-0-12-800877-5.00002-4"},{"key":"3757_CR91","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1471-4159.2011.07576.x","volume":"120","author":"ZS Martin","year":"2012","unstructured":"Martin ZS, Neugebauer V, Dineley KT et al (2012) \u03b1-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases. J Neurochem 120:440\u2013452. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07576.x","journal-title":"J Neurochem"},{"key":"3757_CR92","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.tips.2005.05.002","volume":"26","author":"NB Mercuri","year":"2005","unstructured":"Mercuri NB, Bernardi G (2005) The \u201cmagic\u201d of L-dopa: why is it the gold standard Parkinson\u2019s disease therapy? Trends Pharmacol Sci 26:341\u2013344. https:\/\/doi.org\/10.1016\/j.tips.2005.05.002","journal-title":"Trends Pharmacol Sci"},{"key":"3757_CR93","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1074\/jbc.RA118.005464","volume":"294","author":"ES Michael","year":"2019","unstructured":"Michael ES, Covic L, Kuliopulos A (2019) Trace amine-associated receptor 1 (TAAR1) promotes anti-diabetic signaling in insulin-secreting cells. J Biol Chem 294:4401\u20134411. https:\/\/doi.org\/10.1074\/jbc.RA118.005464","journal-title":"J Biol Chem"},{"key":"3757_CR94","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/J.1471-4159.2010.07109.X","volume":"116","author":"GM Miller","year":"2011","unstructured":"Miller GM (2011) The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity. J Neurochem 116:164\u2013176. https:\/\/doi.org\/10.1111\/J.1471-4159.2010.07109.X","journal-title":"J Neurochem"},{"key":"3757_CR95","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/B978-0-323-95975-9.00011-1","volume-title":"Foundations of the mind, brain, and behavioral relationships","author":"J Moini","year":"2024","unstructured":"Moini J, LoGalbo A, Ahangari R (2024) Chapter 15 - Neurological disorders. In: Moini J, LoGalbo A, Ahangari R (eds) Foundations of the mind, brain, and behavioral relationships. Academic Press, pp 241\u2013267"},{"key":"3757_CR96","doi-asserted-by":"publisher","first-page":"190244","DOI":"10.3389\/FNINS.2016.00148\/BIBTEX","volume":"10","author":"Y Pei","year":"2016","unstructured":"Pei Y, Asif-Malik A, Canales JJ (2016) Trace amines and the trace amine-associated receptor 1: pharmacology, neurochemistry, and clinical implications. Front Neurosci 10:190244. https:\/\/doi.org\/10.3389\/FNINS.2016.00148\/BIBTEX","journal-title":"Front Neurosci"},{"key":"3757_CR97","unstructured":"Pharmaceuticals S (2019a) A clinical trial to study the efficacy and safety of an investigational drug in acutely psychotic people with schizophrenia"},{"key":"3757_CR98","unstructured":"Pharmaceuticals S (2019b) A clinical trial that will study the efficacy and safety of an investigational drug in acutely psychotic people with schizophrenia"},{"key":"3757_CR99","doi-asserted-by":"publisher","first-page":"11569","DOI":"10.3390\/ijms241411569","volume":"24","author":"B Polini","year":"2023","unstructured":"Polini B, Ricardi C, Bertolini A et al (2023) T1AM\/TAAR1 system reduces inflammatory response and \u03b2-amyloid toxicity in human microglial HMC3 cell line. Int J Mol Sci 24:11569. https:\/\/doi.org\/10.3390\/ijms241411569","journal-title":"Int J Mol Sci"},{"key":"3757_CR100","doi-asserted-by":"publisher","first-page":"8485","DOI":"10.1073\/PNAS.1103029108\/-\/DCSUPPLEMENTAL","volume":"108","author":"FG Revel","year":"2011","unstructured":"Revel FG, Moreau JL, Gainetdinov RR et al (2011) TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc Natl Acad Sci U S A 108:8485\u20138490. https:\/\/doi.org\/10.1073\/PNAS.1103029108\/-\/DCSUPPLEMENTAL","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3757_CR101","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.biopsych.2012.05.014","volume":"72","author":"FG Revel","year":"2012","unstructured":"Revel FG, Moreau J-L, Gainetdinov RR et al (2012) Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics. Biol Psychiatry 72:934\u2013942. https:\/\/doi.org\/10.1016\/j.biopsych.2012.05.014","journal-title":"Biol Psychiatry"},{"key":"3757_CR102","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/mp.2012.57","volume":"18","author":"FG Revel","year":"2013","unstructured":"Revel FG, Moreau J-L, Pouzet B et al (2013) A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight. Mol Psychiatry 18:543\u2013556. https:\/\/doi.org\/10.1038\/mp.2012.57","journal-title":"Mol Psychiatry"},{"key":"3757_CR103","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3389\/fphar.2017.00987","volume":"8","author":"G Rutigliano","year":"2017","unstructured":"Rutigliano G, Accorroni A, Zucchi R (2017) The case for TAAR1 as a modulator of central nervous system function. Front Pharmacol 8:987. https:\/\/doi.org\/10.3389\/fphar.2017.00987","journal-title":"Front Pharmacol"},{"key":"3757_CR104","doi-asserted-by":"publisher","first-page":"9153","DOI":"10.3390\/ijms21239153","volume":"21","author":"KC Ryan","year":"2020","unstructured":"Ryan KC, Ashkavand Z, Norman KR (2020) The role of mitochondrial calcium homeostasis in Alzheimer\u2019s and related diseases. Int J Mol Sci 21:9153. https:\/\/doi.org\/10.3390\/ijms21239153","journal-title":"Int J Mol Sci"},{"key":"3757_CR105","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1089\/ars.2015.6522","volume":"25","author":"Y Santin","year":"2016","unstructured":"Santin Y, Sicard P, Vigneron F et al (2016) Oxidative stress by monoamine oxidase-a impairs transcription factor EB activation and autophagosome clearance, leading to cardiomyocyte necrosis and heart failure. Antioxid Redox Signal 25:10\u201327. https:\/\/doi.org\/10.1089\/ars.2015.6522","journal-title":"Antioxid Redox Signal"},{"key":"3757_CR106","doi-asserted-by":"crossref","unstructured":"Sauer AK, Stanton JE, Hans S, Grabrucker AM (2021) Autism spectrum disorders: etiology and pathology. In: Grabrucker AM (ed). Brisbane (AU)","DOI":"10.36255\/exonpublications.autismspectrumdisorders.2021.etiology"},{"key":"3757_CR107","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5312\/wjo.v6.i1.24","volume":"6","author":"N Sezer","year":"2015","unstructured":"Sezer N, Akku\u015f S, U\u011furlu FG (2015) Chronic complications of spinal cord injury. World J Orthop 6:24\u201333. https:\/\/doi.org\/10.5312\/wjo.v6.i1.24","journal-title":"World J Orthop"},{"key":"3757_CR108","doi-asserted-by":"publisher","first-page":"563481","DOI":"10.1155\/2013\/563481","volume":"2013","author":"S Sheikh","year":"2013","unstructured":"Sheikh S, Safia HE, Mir SS (2013) Neurodegenerative diseases: multifactorial conformational diseases and their therapeutic interventions. J Neurodegener Dis 2013:563481. https:\/\/doi.org\/10.1155\/2013\/563481","journal-title":"J Neurodegener Dis"},{"key":"3757_CR109","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1124\/mol.119.116798","volume":"96","author":"X Shi","year":"2019","unstructured":"Shi X, Swanson TL, Miner NB et al (2019) Activation of trace amine-associated receptor 1 stimulates an antiapoptotic signal cascade via extracellular signal-regulated kinase 1\/2. Mol Pharmacol 96:493\u2013504. https:\/\/doi.org\/10.1124\/mol.119.116798","journal-title":"Mol Pharmacol"},{"key":"3757_CR110","doi-asserted-by":"publisher","first-page":"e12992","DOI":"10.1111\/cpr.12992","volume":"54","author":"Z Shi","year":"2021","unstructured":"Shi Z, Yuan S, Shi L et al (2021) Programmed cell death in spinal cord injury pathogenesis and therapy. Cell Prolif 54:e12992. https:\/\/doi.org\/10.1111\/cpr.12992","journal-title":"Cell Prolif"},{"key":"3757_CR111","doi-asserted-by":"publisher","first-page":"e2217396120","DOI":"10.1073\/pnas.2217396120","volume":"120","author":"A Shum","year":"2023","unstructured":"Shum A, Zaichick S, McElroy GS et al (2023) Octopamine metabolically reprograms astrocytes to confer neuroprotection against \u03b1-synuclein. Proc Natl Acad Sci U S A 120:e2217396120. https:\/\/doi.org\/10.1073\/pnas.2217396120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3757_CR112","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0006-8993(76)91010-6","volume":"114","author":"RP Silkaitis","year":"1976","unstructured":"Silkaitis RP, Mosnaim AD (1976) Pathways linking L-phenylalanine and 2-phenylethylamine with p-tyramine in rabbit brain. Brain Res 114:105\u2013115. https:\/\/doi.org\/10.1016\/0006-8993(76)91010-6","journal-title":"Brain Res"},{"issue":"Suppl 2","key":"3757_CR113","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1016\/j.parkreldis.2008.04.006","volume":"14","author":"TD Sotnikova","year":"2008","unstructured":"Sotnikova TD, Zorina OI, Ghisi V et al (2008) Trace amine associated receptor 1 and movement control. Parkinsonism Relat Disord 14(Suppl 2):S99-102. https:\/\/doi.org\/10.1016\/j.parkreldis.2008.04.006","journal-title":"Parkinsonism Relat Disord"},{"key":"3757_CR114","doi-asserted-by":"publisher","first-page":"e13452","DOI":"10.1371\/journal.pone.0013452","volume":"5","author":"TD Sotnikova","year":"2010","unstructured":"Sotnikova TD, Beaulieu J-M, Espinoza S et al (2010) The dopamine metabolite 3-methoxytyramine is a neuromodulator. PLoS One 5:e13452. https:\/\/doi.org\/10.1371\/journal.pone.0013452","journal-title":"PLoS One"},{"key":"3757_CR115","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/brain\/awh322","volume":"128","author":"K Stiasny-Kolster","year":"2005","unstructured":"Stiasny-Kolster K, Doerr Y, M\u00f6ller JC et al (2005) Combination of \u201cidiopathic\u201d REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128:126\u2013137. https:\/\/doi.org\/10.1093\/brain\/awh322","journal-title":"Brain"},{"key":"3757_CR116","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.phrs.2015.11.002","volume":"103","author":"I Sukhanov","year":"2016","unstructured":"Sukhanov I, Caffino L, Efimova EV et al (2016) Increased context-dependent conditioning to amphetamine in mice lacking TAAR1. Pharmacol Res 103:206\u2013214. https:\/\/doi.org\/10.1016\/j.phrs.2015.11.002","journal-title":"Pharmacol Res"},{"key":"3757_CR117","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/258749a0","volume":"258","author":"M Swash","year":"1975","unstructured":"Swash M, Moffett AM, Scott DF (1975) Tyramine activates the EEG in epileptic patients. Nature 258:749\u2013750. https:\/\/doi.org\/10.1038\/258749a0","journal-title":"Nature"},{"key":"3757_CR118","doi-asserted-by":"publisher","first-page":"9754","DOI":"10.1523\/JNEUROSCI.0344-18.2018","volume":"38","author":"PJ Teravskis","year":"2018","unstructured":"Teravskis PJ, Covelo A, Miller EC et al (2018) A53T mutant alpha-synuclein induces tau-dependent postsynaptic impairment independently of neurodegenerative changes. J Neurosci Off J Soc Neurosci 38:9754\u20139767. https:\/\/doi.org\/10.1523\/JNEUROSCI.0344-18.2018","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"3757_CR119","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fncel.2020.00019","volume":"14","author":"D Toral-Rios","year":"2020","unstructured":"Toral-Rios D, Pichardo-Rojas PS, Alonso-Vanegas M, Campos-Pe\u00f1a V (2020) GSK3\u03b2 and tau protein in Alzheimer\u2019s disease and epilepsy. Front Cell Neurosci 14:19. https:\/\/doi.org\/10.3389\/fncel.2020.00019","journal-title":"Front Cell Neurosci"},{"key":"3757_CR120","doi-asserted-by":"publisher","first-page":"105271","DOI":"10.1016\/j.nbd.2021.105271","volume":"151","author":"F Tozzi","year":"2021","unstructured":"Tozzi F, Rutigliano G, Bors\u00f2 M et al (2021) T(1)AM-TAAR1 signalling protects against OGD-induced synaptic dysfunction in the entorhinal cortex. Neurobiol Dis 151:105271. https:\/\/doi.org\/10.1016\/j.nbd.2021.105271","journal-title":"Neurobiol Dis"},{"key":"3757_CR121","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41380-019-0469-2","volume":"26","author":"SM Underhill","year":"2021","unstructured":"Underhill SM, Hullihen PD, Chen J et al (2021) Amphetamines signal through intracellular TAAR1 receptors coupled to G\u03b1(13) and G\u03b1(S) in discrete subcellular domains. Mol Psychiatry 26:1208\u20131223. https:\/\/doi.org\/10.1038\/s41380-019-0469-2","journal-title":"Mol Psychiatry"},{"key":"3757_CR122","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40035-021-00278-7","volume":"11","author":"M Verma","year":"2022","unstructured":"Verma M, Lizama BN, Chu CT (2022) Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration. Transl Neurodegener 11:3. https:\/\/doi.org\/10.1186\/s40035-021-00278-7","journal-title":"Transl Neurodegener"},{"key":"3757_CR123","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-160763","volume":"57","author":"R Wang","year":"2017","unstructured":"Wang R, Reddy PH (2017) Role of glutamate and NMDA receptors in Alzheimer\u2019s disease. J Alzheimers Dis 57:1041\u20131048. https:\/\/doi.org\/10.3233\/JAD-160763","journal-title":"J Alzheimers Dis"},{"key":"3757_CR124","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-59745-543-5_5","volume":"489","author":"X Wang","year":"2009","unstructured":"Wang X, Takano T, Nedergaard M (2009) Astrocytic calcium signaling: mechanism and implications for functional brain imaging. Methods Mol Biol 489:93\u2013109. https:\/\/doi.org\/10.1007\/978-1-59745-543-5_5","journal-title":"Methods Mol Biol"},{"key":"3757_CR125","doi-asserted-by":"publisher","first-page":"173862","DOI":"10.1016\/j.pbb.2024.173862","volume":"245","author":"L Wang","year":"2024","unstructured":"Wang L, Clark EA, Hanratty L et al (2024) TAAR1 and 5-HT(1B) receptor agonists attenuate autism-like irritability and aggression in rats prenatally exposed to valproic acid. Pharmacol Biochem Behav 245:173862. https:\/\/doi.org\/10.1016\/j.pbb.2024.173862","journal-title":"Pharmacol Biochem Behav"},{"key":"3757_CR126","unstructured":"Wen F, Liu L, Xu Z, et al (2017) [Dopamine inhibits glutamate-uptake ability of astrocytes via TAAR1-EAAT2 pathway]. Xi bao yu fen zi mian yi xue za zhi = Chinese J Cell Mol Immunol 33:930\u2013935"},{"key":"3757_CR127","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/BRAIN\/AWX341","volume":"141","author":"CD Whelan","year":"2018","unstructured":"Whelan CD, Altmann A, Bot\u00eda JA et al (2018) Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study. Brain 141:391\u2013408. https:\/\/doi.org\/10.1093\/BRAIN\/AWX341","journal-title":"Brain"},{"key":"3757_CR128","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/j.1601-183X.2006.00292.x","volume":"6","author":"TD Wolinsky","year":"2007","unstructured":"Wolinsky TD, Swanson CJ, Smith KE et al (2007) The trace amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia. Genes Brain Behav 6:628\u2013639. https:\/\/doi.org\/10.1111\/j.1601-183X.2006.00292.x","journal-title":"Genes Brain Behav"},{"key":"3757_CR129","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1124\/jpet.106.117382","volume":"321","author":"Z Xie","year":"2007","unstructured":"Xie Z, Miller GM (2007) Trace amine-associated receptor 1 is a modulator of the dopamine transporter. J Pharmacol Exp Ther 321:128\u2013136. https:\/\/doi.org\/10.1124\/jpet.106.117382","journal-title":"J Pharmacol Exp Ther"},{"key":"3757_CR130","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1124\/JPET.106.116863","volume":"321","author":"Z Xie","year":"2007","unstructured":"Xie Z, Westmoreland SV, Bahn ME et al (2007) Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro. J Pharmacol Exp Ther 321:116\u2013127. https:\/\/doi.org\/10.1124\/JPET.106.116863","journal-title":"J Pharmacol Exp Ther"},{"key":"3757_CR131","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1124\/JPET.107.135079","volume":"325","author":"Z Xie","year":"2008","unstructured":"Xie Z, Westmoreland SV, Miller GM (2008) Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes. J Pharmacol Exp Ther 325:629\u2013640. https:\/\/doi.org\/10.1124\/JPET.107.135079","journal-title":"J Pharmacol Exp Ther"},{"key":"3757_CR132","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12035-012-8332-3","volume":"47","author":"H-H Yuan","year":"2013","unstructured":"Yuan H-H, Chen R-J, Zhu Y-H et al (2013) The neuroprotective effect of overexpression of calbindin-D(28k) in an animal model of Parkinson\u2019s disease. Mol Neurobiol 47:117\u2013122. https:\/\/doi.org\/10.1007\/s12035-012-8332-3","journal-title":"Mol Neurobiol"},{"key":"3757_CR133","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1159\/000447912","volume":"39","author":"C Zhang","year":"2016","unstructured":"Zhang C, Liu S, Yuan X et al (2016) Valproic acid promotes human glioma U87 cells apoptosis and inhibits glycogen synthase kinase-3\u03b2 through ERK\/Akt signaling. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol 39:2173\u20132185. https:\/\/doi.org\/10.1159\/000447912","journal-title":"Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol"},{"key":"3757_CR134","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1179\/1743132812Y.0000000025","volume":"34","author":"S Zhao","year":"2012","unstructured":"Zhao S, Fu J, Liu X et al (2012) Activation of Akt\/GSK-3beta\/beta-catenin signaling pathway is involved in survival of neurons after traumatic brain injury in rats. Neurol Res 34:400\u2013407. https:\/\/doi.org\/10.1179\/1743132812Y.0000000025","journal-title":"Neurol Res"},{"key":"3757_CR135","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fphys.2014.00402","volume":"5","author":"R Zucchi","year":"2014","unstructured":"Zucchi R, Accorroni A, Chiellini G (2014) Update on 3-iodothyronamine and its neurological and metabolic actions. Front Physiol 5:402. https:\/\/doi.org\/10.3389\/fphys.2014.00402","journal-title":"Front Physiol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03757-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03757-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03757-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T08:17:27Z","timestamp":1744273047000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03757-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":135,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3757"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03757-6","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"7 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}